Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations

Global Heart
Amy R Bentley, Charles N Rotimi

Abstract

African Americans generally have a healthier lipid profile (lower triglycerides and higher high-density lipoprotein cholesterol concentration) compared with those of other ethnicities. Paradoxically, African Americans do not experience a decreased risk of the cardiometabolic diseases that serum lipids are expected to predict. This review explores this mismatch between biomarker and disease among African ancestry individuals by investigating the presence of interethnic differences in the biological relationships underlying the serum lipids-disease association. This review also discusses the physiologic and genomic factors underlying these interethnic differences. Additionally, because of the importance of serum lipids in assessing disease risk, interethnic differences in serum lipids have implications for identifying African ancestry individuals at risk of cardiometabolic disease. Where possible, data from Africa is included, to further elucidate these ancestral differences in the context of a different environmental background.

References

Apr 1, 1995·The American Journal of Clinical Nutrition·J M ConwayV S Hubbard
Sep 24, 2004·Atherosclerosis·Johanna L JohnsonWilliam E Kraus
Jul 1, 2005·Metabolism: Clinical and Experimental·Anne E SumnerRaymond C Boston
Dec 7, 2005·Circulation·Krisela SteynUNKNOWN INTERHEART Investigators in Africa
Aug 30, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R DroletA Tchernof
Mar 21, 2008·The New England Journal of Medicine·Sekar KathiresanMarju Orho-Melander
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Barbara A GowerFernando Ovalle
Jun 21, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Martin AdielsJan Borén
Dec 24, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard GuerreroJeffrey D Browning
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Pia R KamstrupBørge G Nordestgaard
Jun 19, 2009·American Journal of Preventive Medicine·Shifan DaiDarwin R Labarthe
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Aug 25, 2009·Atherosclerosis·Mingfang LiBernard M Y Cheung
Oct 16, 2009·The American Journal of Clinical Nutrition·Peter T KatzmarzykClaude Bouchard
Nov 21, 2009·Obesity·Herman A TaylorCaroline Fox
Jan 26, 2010·Metabolism: Clinical and Experimental·Julia H GoedeckeSteven E Kahn
Apr 29, 2010·Current Diabetes Reports·Kwame Osei
May 7, 2010·The Journal of Clinical Endocrinology and Metabolism·Rebecca E HassonMichael I Goran
Jun 25, 2010·The American Journal of Clinical Nutrition·Ebe D'AdamoSonia Caprio
Aug 6, 2010·Nature·Tanya M TeslovichSekar Kathiresan
Sep 17, 2010·The Journal of Clinical Endocrinology and Metabolism·Jiankang LiuHerman A Taylor
Oct 12, 2010·Nature Genetics·Elizabeth K SpeliotesRuth J F Loos

❮ Previous
Next ❯

Citations

Oct 5, 2017·Human Molecular Genetics·Charles N RotimiAdebowale Adeyemo
Oct 1, 2019·BMJ Global Health·Ana Luiza G SoaresAmelia Crampin
Feb 2, 2020·Lipids in Health and Disease·Fatemeh Azizi-SoleimanRoya Kelishadi
Mar 13, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Gibson B KagarukiBassirou Bonfoh
Mar 18, 2021·International Journal of Epidemiology·Kenneth EkoruCharles N Rotimi
Sep 18, 2021·Epigenetics : Official Journal of the DNA Methylation Society·Steven R H BeachRobert A Philibert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.